ArticleJournal of clinical laboratory analysis2026
Resolving a Complex Neonatal Phenotype by Rapid Trio Whole-Genome Sequencing: A De Novo 11q14.3-q22.3 Deletion and a Splicing-Altering Synonymous ANK1 Variant.
Article in Journal of clinical laboratory analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundNeonates with complex and evolving phenotypes often lack sufficiently specific clinical features to guide targeted genetic testing. Rapid trio whole-genome sequencing (WGS) may provide comprehensive etiologic clarification by simultaneously detecting sequence and structural variants.
methodsRapid trio WGS was performed in a preterm infant with dysmorphic features, cardiac anomalies, hemolytic anemia, and persistent intrahepatic cholestasis, together with her parents. A copy number variant was confirmed by chromosomal microarray analysis. The functional effect of a candidate single nucleotide variant was investigated using SpliceAI, reverse transcription PCR, agarose gel electrophoresis, and Sanger sequencing.
resultsThe genetic diagnosis was achieved within 10 days. WGS identified a de novo heterozygous 15.6 Mb deletion at chromosome 11q14.3-q22.3, which was classified as pathogenic and accounted for the infant's congenital anomalies. A novel paternally inherited ANK1 synonymous variant, NM_000037.4:c.4104G>A was also identified, and its RNA analysis demonstrated exon 33 skipping, resulting in an in-frame deletion. Although the variant was classified as a variant of uncertain significance, its demonstrated splicing effect and the concordant spherocytosis phenotype in the infant and her father supported its clinical relevance. This integrated diagnosis informed surveillance, genetic counseling, and evaluation of the persistent cholestasis while avoiding further invasive investigation.
conclusionRapid trio WGS, complemented by functional RNA analysis, resolved distinct components of a complex neonatal phenotype by identifying both a pathogenic chromosomal deletion and a splicing-altering synonymous ANK1 variant. This case demonstrates the value of comprehensive genomic testing for precision diagnosis and individualized management in neonatal medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.